Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019043232) A FASCIOLA HEPATICA ANTIGEN AND VACCINE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/043232 International Application No.: PCT/EP2018/073640
Publication Date: 07.03.2019 International Filing Date: 03.09.2018
IPC:
C07K 14/435 (2006.01) ,A61K 39/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
Applicants:
THE QUEEN'S UNIVERSITY OF BELFAST [GB/GB]; University Road Belfast Antrim BT7 1NN, GB
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN [IE/IE]; Belfield Dublin, 4, IE
Inventors:
MULCAHY, Grace; IE
GARZA-CUARTERO, Laura; IE
DALTON, John; GB
Agent:
FRKELLY; 27 Clyde Road Dublin, D04 F838, IE
Priority Data:
1714057.501.09.2017GB
Title (EN) A FASCIOLA HEPATICA ANTIGEN AND VACCINE
(FR) ANTIGÈNE ET VACCIN DE FASCIOLA HEPATICA
Abstract:
(EN) The present invention is related to a Fasciola hepatica antigen and vaccine. Specifically, the present invention relates to a Fasciola hepatica antigen comprising a polypeptide, wherein the polypeptide comprises amino acid sequences from Fasciola hepatica, or fragments each thereof. Also disclosed are use of the antigen as a vaccine against Fasciola hepatica infection, and use of the antigen in the manufacture of a vaccine for vaccinating a subject against Fasciola hepatica infection.
(FR) La présente invention concerne un antigène et un vaccin de Fasciola hepatica. De façon plus spécifique, la présente invention concerne un antigène de Fasciola hepatica qui comprend un polypeptide, le polypeptide comprenant des séquences d'acides aminés provenant de Fasciola hepatica ou des fragments de ceux-ci. L'invention porte également sur l'utilisation de l'antigène en tant que vaccin contre une infection par Fasciola hepatica, et sur l'utilisation de l'antigène dans la fabrication d'un vaccin pour la vaccination d'un sujet contre une infection par Fasciola hepatica.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)